Oral PI3K/mTOR inhibitor

· Piramal Enterprises Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral PI3K/mTOR inhibitor, covering 2014-09-29 to 2014-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors [Phase 1]